5-substituted-5-hydroxy-5-aryl-3-oxo-pentanoate derivatives and their enantiopure forms

US2018118648A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018118648-A1
Application numberUS-201615560868-A
CountryUS
Kind codeA1
Filing dateFeb 1, 2016
Priority dateMar 24, 2015
Publication dateMay 3, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to novel tertiary alcohol derivatives substituted with aryl and trifluoromethyl, and optical isomers thereof. In addition, the present invention also relates to methods for the preparation and use as enantiomer recognition agent thereof. The present invention provides pharmaceutical composition and use as therapeutically active substance thereof.

First claim

Opening claim text (preview).

1 . A compound of formula I: wherein A is B is aryl which is substituted with one or more groups selected from the group consisting of C 1-7 -alkyl, halogen, halogen-C 1-7 -alkyl, C 1-7 -alkoxy, halogen-C 1-7 -alkoxy, hydroxy, cyano, and nitro, or is heteroaryl, which is unsubstitued or substituted with one or more groups selected from the group consisting of C 1-7 -alkyl, halogen, halogen-C 1-7 -alkyl, C 1-7 -alkoxy, halogen-C 1-7 -alkoxy, hydroxy, cyano, and nitro; R 1 and R 1′ may be the same or different and each is independently selected from the group consisting of C 1-7 -alkyl, halogen-C 1-7 -alkyl, and C 1-7 -alkyl substituted with one or more C 1-7 -alkoxy; or R 1 and R 1′ may together form C 1-7 -alkylene; R 2 is selected from the group consisting of C 1-7 -alkyl, halogen-C 1-7 -alkyl, C 1-7 -alkoxy, C 3-7 -cycloalkyloxy, halogen-C 1-7 -alkoxy, C 1-7 -alkoxy substituted with one or more C 1-7 -alkyl, and hydroxy; R 3 is selected from the group consisting of hydrogen, halogen, C 1-7 -alkyl, halogen-C 1-7 -alkyl, hydroxy-C 1-7 -alkyl, C 1-7 -alkoxy, and halogen-C 1-7 -alkoxy; and n is 1, 2, 3, or 4; or a salt thereof. 2 . The compound of formula I or salt thereof according to claim 1 , wherein B is aryl which is substituted with one or more groups selected from the group consisting of C 1-7 -alkyl, halogen, halogen-C 1-7 -alkyl, C 1-7 -alkoxy, and halogen-C 1-7 -alkoxy, or is heteroaryl which is unsubstitued or substituted with one or more groups selected from the group consisting of C 1-7 -alkyl, halogen, halogen-C 1-7 -alkyl, C 1-7 -alkoxy, and halogen-C 1-7 -alkoxy. 3 . The compound of formula I or salt thereof according to claim 1 , wherein R 1 and R 1′ may be the same or different and each is independently selected from the group consisting of C 1-7 -alkyl, halogen-C 1-7 -alkyl and C 1-7 -alkyl substituted with one or more C 1-7 -alkoxy. 4 . The compound of formula I or salt thereof according to claim 1 , wherein R 2 is selected from the group consisting of C 1-7 -alkyl, halogen-C 1-7 -alkyl, C 1-7 -alkoxy, halogen-C 1-7 -alkoxy, and C 1-7 -alkoxy substituted with one or more C 1-7 -alkyl. 5 . The compound of formula I or salt thereof according to claim 1 , wherein R 3 is selected from the group consisting of hydrogen, halogen and C 1-7 -alkyl. 6 . The compound of formula I or salt thereof according to claim 1 , wherein n is 1 or 2. 7 . The compound of formula I according to claim 1 , which is selected from the group consisting of 5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-phenylpentan-2-one, (R)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-phenylpentan-2-one, (S)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-phenylpentan-2-one, 4-(4-chlorophenyl)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxypentan-2-one, (R)-4-(4-chlorophenyl)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxypentan-2-one, (S)-4-(4-chlorophenyl)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxypentan-2-one, 4-(4-bromophenyl)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxypentan-2-one, (R)-4-(4-bromophenyl)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxypentan-2-one, (S)-4-(4-bromophenyl)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxypentan-2-one, 5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(4-(trifluoromethyl)phenyl)pentan-2-one, (R)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(4-(trifluoromethyl)phenyl)pentan-2-one, (S)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(4-(trifluoromethyl)phenyl)pentan-2-one, 5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(p-tolyl)pentan-2-one, (R)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(p-tolyl)pentan-2-one, (S)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(p-tolyl)pentan-2-one, 5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(4-methoxyphenyl)pentan-2-one, (R)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(4-methoxyphenyl)pentan-2-one, (S)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(4-methoxyphenyl)pentan-2-one, 5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(thiophen-2-yl)pentan-2-one, (R)-5, 5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(thiophen-2-yl)pentan-2-one, (S)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(thiophen-2-yl)pentan-2-one, 5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(1H-pyrrol-2-yl)pentan-2-one, (R)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(1H-pyrrol-2-yl)pentan-2-one, (S)-5,5,5-trifluoro-4-hydroxy-1,1-dimethoxy-4-(1H-pyrrol-2-yl)pentan-2-one, ethyl 6,6,6-trifluoro-5-hydroxy-3-oxo-5-phenylhexanoate, (R)-ethyl 6,6,6-trifluoro-5-hydroxy-3-oxo-5-phenylhexanoate, (S)-ethyl 6,6,6-trifluoro-5-hydroxy-3-oxo-5-phenylhexanoate, ethyl 6,6,6-trifluoro-5-hydroxy-2-methyl-3-oxo-5-phenylhexanoate, (R)-ethyl 6,6,6-trifluoro-5-hydroxy-2-methyl-3-oxo-5-phenylhexanoate, (S)-ethyl 6,6,6-trifluoro-5-hydroxy-2-methyl-3-oxo-5-phenylhexanoate, ethyl 6,6,6-trifluoro-5-hydroxy-5-(4-methoxyphenyl)-3-oxohexanoate, (R)-ethyl 6,6,6-trifluoro-5-hydroxy-5-(4-methoxyphenyl)-3-oxohexanoate, (S)-ethyl 6,6,6-trifluoro-5-hydroxy-5-(4-methoxyphenyl)-3-oxohexanoate, ethyl 5-(4-chlorophenyl)-6,6,6-trifluoro-5-hydroxy-3-oxohexanoate, (R)-ethyl 5-(4-chlorophenyl)-6,6,6-trifluoro-5-hydroxy-3-oxohexanoate, (S)-ethyl 5-(4-chlorophenyl)-6,6,6-trifluoro-5-hydroxy-3-oxohexanoate, ethyl 6,6,6-trifluoro-5-hydroxy-3-oxo-5-(thiophen-2-yl)hexanoate, (R)-ethyl 6,6,6-trifluoro-5-hydroxy-3-oxo-5-(thiophen-2-yl)hexanoate, (S)-ethyl 6,6,6-trifluoro-5-hydroxy-3-oxo-5-(thiophen-2-yl)hexanoate, ethyl 6,6,6-trifluoro-5-hydroxy-5-(4-methoxyphenyl)-2-methyl-3-oxohexanoate, (R)-ethyl 6,6,6-trifluoro-5-hydroxy-5-(4-methoxyphenyl)-2-methyl-3-oxohexanoate, (S)-ethyl 6,6,6-trifluoro-5-hydroxy-5-(4-methoxyphenyl)-2-methyl-3-oxohexanoate, ethyl 5-(4-chlorophenyl)-6,6,6-trifluoro-5-hydroxy-2-methyl-3-oxohexanoate, (R)-ethyl 5-(4-chlorophenyl)-6,6,6-trifluoro-5-hydroxy-2-methyl-3-oxohexanoate, (S)-ethyl 5-(4-chlorophenyl)-6,6,6-trifluoro-5-hydroxy-2-methyl-3-oxohexanoate, ethyl 6,6,6-trifluoro-5-hydroxy-2-methyl-3-oxo-5-(thiophen-2-yl)hexanoate, (R)-ethyl 6,6,6-trifluoro-5-hydroxy-2-methyl-3-oxo-5-(thiophen-2-yl)hexanoate, (S)-ethyl 6,6,6-trifluoro-5-hydroxy-2-methyl-3-oxo-5-(thiophen-2-yl)hexanoate, (R)-ethyl 6,6,6-trifluoro-5-hydroxy-5-phenyl-3-(((R)-1-phenylethyl)amino)hex-2-enoate, (S)-ethyl 6,6,6-trifluoro-5-hydroxy-3-(((R)-1-phenylethyl)amino)-5-(thiophen-2-yl)hex-2-enoate, 3-(3,3,3-trifluoro-2-hydroxy-2-phenylpropyl)cyclohex-2-enone, (R)-3-(3,3,3-trifluoro-2-hydroxy-2-phenyl propyl)cyclohex-2-enone, (S)-3-(3,3,3-trifluoro-2-hydroxy-2-phenyl propyl)cyclohex-2-enone, 3-(3,3,3-trifluoro-2-hydroxy-2-(p-tolyl)propyl)cyclohex-2-enone, (R)-3-(3,3,3-trifluoro-2-hydroxy-2-(p-tolyl)propyl)cyclohex-2-enone, (S)-3-(3,3,3-trifluoro-2-hydroxy-2-(p-tolyl)propyl)cyclohex-2-enone, 3-(3,3,3-trifluoro-2-hydroxy-2-(4-methoxyphenyl)propyl)cyclohex-2-enone, (R)-3-(3,3,3-trifluoro-2-hydroxy-2-(4-methoxyphenyl)propyl)cyclohex-2-enone, (S)-3-(3,3,3-trifluoro-2-hydroxy-2-(4-methoxyphenyl)propyl)cyclohex-2-enone, 3-(2-(4-chlorophenyl)-3,3,3-trifluoro-2-hydroxypropyl)cyclohex-2-enone, (R)-3-(2-(4-chlorophenyl)-3,3,3-trifluoro-2-hydroxypropyl)cyclohex-2-enone, (S)-3-(2-(4-chlorophenyl)-3,3,3-trifluoro-2-hydroxypropyl)cyclohex-2-enone, 3-(2-(4-bromophenyl)-3,3,3-trifluoro-2-hydroxypropyl)cyclohex-2-enone, (R)-3-(2-(4-bromophenyl)-3,3,3-trifluoro-2-hydroxypropyl)cyclohex-2-enone, (S)-3-(2-(4-bromophenyl)-3,3,3-trifluoro-2-hydroxypropyl)cyclohex-2-enone, 3-(3,3,3-trifluoro-2-hydroxy-2-(4-(trifluoromethyl)phenyl)propyl)cyclohex-2-enone, (R)-3-(3,3,3-trifluoro-2-hydroxy-2-(4-(trifluoromethyl)phenyl)propyl)cyclohex-2-enone,

Assignees

Inventors

Classifications

  • by separation of optical isomers · CPC title

  • Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates · CPC title

  • with simultaneously increasing the number of carbon atoms in the carbon skeleton · CPC title

  • Halogenated hydrocarbons · CPC title

  • Esters of keto-carboxylic acids {or aldehydo-carboxylic acids} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018118648A1 cover?
The present invention relates to novel tertiary alcohol derivatives substituted with aryl and trifluoromethyl, and optical isomers thereof. In addition, the present invention also relates to methods for the preparation and use as enantiomer recognition agent thereof. The present invention provides pharmaceutical composition and use as therapeutically active substance thereof.
Who is the assignee on this patent?
Okinawa Inst Science & Tech School Corp, Okinawa Inst Science & Tech School Corp
What technology area does this patent fall under?
Primary CPC classification C07C49/753. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu May 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).